Cargando…
Protecting future antimalarials from the trap of resistance: Lessons from artemisinin-based combination therapy (ACT) failures
Having faced increased clinical treatment failures with dihydroartemisinin-piperaquine (DHA-PPQ), Cambodia swapped the first line artemisinin-based combination therapy (ACT) from DHA-PPQ to artesunate-mefloquine given that parasites resistant to piperaquine are susceptible to mefloquine. However, tr...
Autores principales: | Erhunse, Nekpen, Sahal, Dinkar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572664/ https://www.ncbi.nlm.nih.gov/pubmed/34765267 http://dx.doi.org/10.1016/j.jpha.2020.07.005 |
Ejemplares similares
-
Assessment of antimalarial medicinal plants used in Nigerian ethnomedicine reveals antimalarial potential of Cucurbita pepo leaf extract
por: Ezeani, Chinelo, et al.
Publicado: (2022) -
In vitro antiplasmodial activity, cytotoxicity, and gas chromatography – flame ionization detector metabolites fingerprint of extracts and fractions from Tetrorchidium didymostemon
por: Ebohon, Osamudiamen, et al.
Publicado: (2021) -
Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs)
por: Kindermans, Jean-Marie, et al.
Publicado: (2007) -
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023) -
Drug resistance genomics of the antimalarial drug artemisinin
por: Winzeler, Elizabeth A, et al.
Publicado: (2014)